Eli Lilly | Laba Kotor Pada Penjualan



Gross Profit On Sales Perubahan Tanggal
AbbVie USD 10.71B 458M 2024-12
Abbott USD 5.92B 114M 2025-03
ALKERMES USD 146.5M 168.54M 2024-12
Amgen USD 5.97B 781M 2024-12
AstraZeneca USD 11.35B 819M 2025-03
Baxter International USD 1.02B 19M 2024-12
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 11.13B 1.86B 2024-12
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Glaxosmithkline GBP 5.6B 94M 2024-12
Indivior 222M 54M 2025-03
J&J USD 14.6B 816M 2025-03
Medtronic USD 5.52B 49M 2025-01
Merck USD 12.77B 849M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Novartis USD 10.23B 294M 2024-12
Novartis USD 10.24B 313M 2024-12
Novo Nordisk 60B 2.22B 2024-09
Perrigo USD 385.9M 18.5M 2024-12
Pfizer USD 11.12B 987M 2025-03
Prestige Brands USD 161.05M 3.67M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
Sanofi EUR 5.36B 4.71B 2024-12
United Therapeutics USD 701.9M 41.9M 2025-03
Zoetis USD 1.61B 79M 2024-12



Eli Lilly Laba Kotor Pada Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.